These clones constitute 41.0, 6.7 and 12.6% of activated CD4+ T cells and 29.9, 4.7 and 0% of Treg cells in tumors, tumor draining lymph nodes and control lymph nodes respectively. Here, CD4 is linked to neoplasm.